All Posts

On March 16, 2018, a federal judge granted HTC’s motion to dismiss with leave to amend in Electronic Scripting Products, Inc. v. HTC America, Inc. et al.  In this case, Electronic Scripting Products, Inc. (ESPI) sued both HTC America, Inc. (HTC), a designer and manufacturer of mobile devices, and Valve Corporation (Valve), an American video […]

On February 23, 2018, the state of Texas became the most recent state to recognize an evidentiary privilege for patent agent communications with clients. The Supreme Court of Texas, in In re Silver, extended the existing attorney-client privilege doctrine to include communications with a patent agent, reasoning that patent agents, acting within the scope of […]

On October 16, four patents for Allergan’s second best-selling product, the dry-eye treatment Restasis, were invalidated by a federal judge in a Hatch-Waxman Act case for patent infringement. United States Circuit Judge William C. Bryson of the Eastern District of Texas ruled that although Allergan had proved the defendants’ infringement of the Restasis patents at […]